chrisvoncsefalvay/vaers-outcomes huggingface dataset:
itchiness; rash returned on the ninth day much bigger and covered much larger area roughly 3 to 4 inches; intense nausea, never felt like that; small rash; slightly sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (slightly sore arm), PRURITUS (itchiness), RASH (rash returned on the ninth day much bigger and covered much larger area roughly 3 to 4 inches), RASH (small rash) and NAUSEA (intense nausea, never felt like that) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029C20A) for COVID-19 vaccination.     Concurrent medical conditions included Prostate cancer since 09-Apr-2010, Lipodermatosclerosis since 21-Feb-2019, Hypertension (High (Managed with medication (Toprol, hydrochlorothiazide)) since 1987 and Hearing loss (Hearing aids) since 2004. Concomitant products included METOPROLOL SUCCINATE (TOPROL XL) from 1992 to an unknown date, HYDROCHLOROTHIAZIDE from November 2020 to an unknown date, METFORMIN from 2014 to an unknown date, PANTOPRAZOLE SODIUM from 2014 to an unknown date and LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) from 2002 to an unknown date for an unknown indication.    On 19-Jan-2021 at 5:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (slightly sore arm). On 20-Jan-2021, the patient experienced RASH (small rash). On 28-Jan-2021, the patient experienced RASH (rash returned on the ninth day much bigger and covered much larger area roughly 3 to 4 inches). 28-Jan-2021, the patient experienced NAUSEA (intense nausea, never felt like that). On an unknown date, the patient experienced PRURITUS (itchiness). The patient was treated with CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) at an unspecified dose and frequency. On 20-Jan-2021, RASH (small rash) had resolved. On 29-Jan-2021, PRURITUS (itchiness) and NAUSEA (intense nausea, never felt like that) had resolved. On 05-Feb-2021, RASH (rash returned on the ninth day much bigger and covered much larger area roughly 3 to 4 inches) had resolved. At the time of the report, PAIN IN EXTREMITY (slightly sore arm) had resolved. slightly          Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-227517 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Follow-up information received on 18-JUN-2021, contains non-significant information
Patient came to pharmacy complaining that 5 days after shot her arm felt weak and she could not lift it above a certain point. It was not red or hot to touch. She said that it only hurt when she moved it a certain way. I told her to seek medical attention and have her doctor look at it and see what they think.
Shortly after receiving the second Pfizer shot I developed extremely severe spasms and cramping throughout my chest and back.  The pain level is profound and unrelenting and has not changed in two months.  Pain free time is rare, 50% of every day is spent trying to survive the pain, but I am frequently at the hospital.  I cannot eat or sleep or work and dropping weight dangerously fast.    I am completely incapacitated and now have a caretaker
Patient received 1st dose of Pfizer COVID vaccine on 3/31/21. Patient developed COVID symptoms ~ 4/3 and tested positive for COVID on 4/9/21. Patient was exposed to someone who was also found to be COVID positive. Patient presented to the ER with fever, cough, congestion, chest pain, body aches, and shortness of breath on 4/10/21 and was admitted to the hospital for COVID treatment.
COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID) (seriousness criterion hospitalization). At the time of the report, COVID-19 (COVID) outcome was unknown.            Relevant concomitant product usage were not reported by the reporter. No treatment details were added.  Reported that currently in the hospital with COVID. patient received both doses of Moderna probably two months ago, patient was asking her condition was COVID or a variant.  Company Comment : Based on the current available information, the mRNA-1273 does not contain a virus capable of causing COVID-19 infection after vaccination. Therefore causality for COVID 19 is assessed as not applicable.; Sender's Comments: Based on the current available information, the mRNA-1273 does not contain a virus capable of causing COVID-19 infection after vaccination. Therefore causality for COVID 19 is assessed as not applicable. .
Rash and swelling on and off since she received her first dose of the vaccination against SARS-CoV2 virus on Sept 2. The patient states that starting on Sept 9th, the patient had swelling of her lips which resolved the following day, then over the next 2 weeks she experienced swelling throughout different parts of her body such as her right foot, right hand, one of her fingers, her face, and she also developed hives and large welts on her hips.   At no time did she have difficulty breathing or swallowing and has not felt that her tongue has been swollen.   Has never had a reaction to vaccinations or anything in the past. She is not taking any medications or over the counter vitamins or supplements.   Currently treating with antihistamines and prednisone
Initially when received at Department of Health, 50 mg of Benedryl given (mild shortness of breath, itchiness).  Seen in Emergency Department on 10/06/2021, severe chest pain, SOB, bilateral LE muscle cramps w/difficulty in balance.
Fever for 3 days 101 -102 very hard to break, and day 4-5 broke out with rash over chest and back down on penis and growin area. It is day 5 now Saturday night and I am doing research on what to do, baby is sleeping now with rash and no fever.
3hr p/vax pt exp tingling of the arms, hands, & feet as well as facial flushing, tinnitus & a metallic taste;
Flu like symptoms; I felt hot but wasn't running a fever; Felt like crap; Pain in arm; Felt like my whole body got hit by a truck; Wanted to curl up and go back to sleep for a while; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (I felt hot but wasn't running a fever), ASTHENIA (Felt like crap), VACCINATION SITE PAIN (Pain in arm) and MYALGIA (Felt like my whole body got hit by a truck) in a 40-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESOMEPRAZOLE for Acid reflux (esophageal), CELECOXIB for Neck pain, VALACICLOVIR HYDROCHLORIDE (VALTREX) for Shingles, VALPROATE SEMISODIUM (DEPAKOTE ER), PALIPERIDONE (INVEGA [PALIPERIDONE]), LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (I felt hot but wasn't running a fever), ASTHENIA (Felt like crap), VACCINATION SITE PAIN (Pain in arm), MYALGIA (Felt like my whole body got hit by a truck) and FATIGUE (Wanted to curl up and go back to sleep for a while). The patient was treated with NAPROXEN SODIUM (ALEVE) for Vaccination site pain and Myalgia, at an unspecified dose and frequency. On 29-Mar-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (I felt hot but wasn't running a fever), ASTHENIA (Felt like crap), VACCINATION SITE PAIN (Pain in arm), MYALGIA (Felt like my whole body got hit by a truck) and FATIGUE (Wanted to curl up and go back to sleep for a while) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Had sore throat and "swollen glands" within 12 hours of vaccination, which attributed to side effect of HD vaccine.(Mon) Felt fine next day (Tues)  Had a can of diet AW root beer with lunch on Wed, and by 4 pm had a severe sore throat, swollen glands.  Had to rest, take Advil, suck losenges, and drink tea.   Better Thursday but then developed angular cheilitis/small cold sore following week, which is rare
28NOV recvd vax  7AM  & exp h/a 6hrs later;
Three days after vaccine administration, I woke with stiffness / arthritic tips of fingers on right hand and toes on right foot. The joint stiffness continued to get worse on my right side and on the eleventh day after vaccination, I developed sciatica so badly that my right leg was so weak and could not be used to go up stairs; walking and sitting / standing were extremely painful.  The sciatica and neuropathy / arthritic joint pain went away on my right side at approximately eighteen days after vaccination. But then the joint stiffness / neuropathy emerged on my left side (in the tips of fingers on my left hand and in the toes on my left leg). Within a few days I then also developed intense pain in my left hip joint which made it difficult to move my left leg.  These symptoms went away as of six weeks after vaccination.  Today is my seventh week after vaccination and the only lingering symptoms are slight neuropathy / stiffness in the tips of my fingers and toes on my right side.
Nausea, diarrhea, dizziness, disorientation, shakes, headache, injection site pain - all started around 1 pm March 8 and subsided by 8 am March 9
slurred speech; confusion; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 06Apr2021 09:30 (Lot number: ER8729) at the age of 65 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DYSARTHRIA (non-serious) with onset 07Apr2021 12:00, outcome "unknown", described as "slurred speech"; CONFUSIONAL STATE (non-serious) with onset 07Apr2021 12:00, outcome "unknown", described as "confusion". Therapeutic measures were not taken as a result of dysarthria, confusional state. Additional information: Patient did not administer other vaccine in four week. Patient did not tested COVID prior vaccination nor post vaccination.  No follow-up attempts are possible. No further information is expected.
Prickling on the inside of the skin that turned into bumps much like chickenpox but small with fluid in the upper part of the body spread out on the left arm and right arm, and the rest of the body only a few of them.
Rotarix administered iM; reconstituted Rotarixwith normal saline; Rotarix administered iM; This case was reported by a physician via call center representative and described the occurrence of inappropriate route of vaccination in a 4-month-old patient who received Rota (Rotarix lyophilized formulation) (batch number 322CM, expiry date 15th February 2024) for prophylaxis.   Co-suspect products included rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator for prophylaxis.   On 2nd September 2022, the patient received Rotarix lyophilized formulation (intramuscular) and Rotarix Oral Applicator Device. On 2nd September 2022, unknown after receiving Rotarix lyophilized formulation and Rotarix Oral Applicator Device, the patient experienced inappropriate route of vaccination, wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate route of vaccination, wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 02-SEP-2022 Reporter's comment: Medical Doctor reported they inadvertently reconstituted Rotarix lyophilized component with normal saline then administered intramuscularly to a patient. The reporter did not provide any additional details. Medical Doctor called to inquire what to do. The reporter did not consent to follow-up. Additional Supportive Information: The patient received dose of Rotarix lyophilized intramuscularly which was inadvertently reconstituted with normal saline, which led to inappropriate route of vaccination, wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.
Complained vaccine was burning - even after needle was pulled out. Stated strange sensation can down arm to neck & jaw - couldn't differentiate pain vs strange sensation. No treatment administered. Pt said she was ok. I called her an hour later - she was running errands but still had a slight off sensation.
Symptoms presented within 24hrs of inoculation, presented to clinic at 72-hr mark. Consolidated rash of firm papules 1-3mm diameter, erythema involving bilateral axillae, inguinal folds, sparing areas of dense hair growth. Individual, discrete lesions on bilateral upper extremities, lower extremities, torso. No discharge noted from lesions. Mildly pruritic, pain/burning sensation in axillae, groin. IM dexamethasone provided in clinic, topical 1% hydrocortisone PRN for axillae, groin. Treatment efficacy unknown at this time (24hr post treatment).
This spontaneous report was received from a registered nurse and refers to a female patient of an unknown age. The patient's concurrent conditions, medical history and concomitant therapies were not reported. The patient received one dose of (wistar ra 27-3) M-M-R II on an unspecified date in 2010. On an unknown date, the patient became pregnant (the date of last menstrual period was not provided). On 04-OCT-2016, the patient was vaccinated with (wistar ra 27-3) M-M-R II injection (dose, route of administrations, lot #, albumin status and expiration date were not reported). The healthcare professional who administered the (wistar ra 27-3) M-M-R II could not be confirmed but it was not the physician listed in this case. The administration of the (wistar ra 27-3) M-M-R II was required by the patient's place of employment. At the time of administration of the (wistar ra 27-3) M-M-R II on 04-OCT-2016, the patient did not know she was pregnant. The patient did not report any adverse effect. The nurse did not supply the patient's specific demographic data. The outcome of the pregnancy was pending. It was reported that no treatment was given and no laboratory diagnostic studies were performed. Additional information has been requested.
Vaccination adverse reaction; This spontaneous case was reported by an other health care professional and describes the occurrence of IMMUNISATION REACTION (Vaccination adverse reaction) in a 47-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS5051C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced IMMUNISATION REACTION (Vaccination adverse reaction). At the time of the report, IMMUNISATION REACTION (Vaccination adverse reaction) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact
On 3/17/21 15:05 Inmate arrives via ambulance due to SOB, fever and chills and 02 sats at 88% since 9 am per EMS report given to hospital ER.  On 3/19/21 pt transferred to a different hospital via EMS. Inmate had 2nd hospitalization on 5/3/21 for SOB again and then was d/c'd on 5/6/21 with dx of mild to moderate Pulmonary Edema, Cardiomegaly, small bilateral effusion.
This case was reported by a pharmacist and described the occurrence of red rash injection site in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). In October 2008, the subject received a dose of FLUARIX (.5 ml, unknown). In October 2008, at an unspecified time after vaccination with FLUARIX, the subject experienced red rash injection site and pharmaceutical product complaint. The pharmacist received a call from a nurse at a nursing home facility that reported that 80 out of 100 subjects developed a "grapefruit size bright red" rash at the injection site. At the time of reporting the outcome of the events was unspecified. For the other 70 linked subjects please see cases: A0756483A - A0756523A, A0756525A - A0756562A. The CRC provided lot number AFLUA3208A to QA regarding this product complaint, while the report received in CMG Safety stated AFLUA3508A. With a possibility of a coding mistake to batch AFLUA 320AA and on the basis that there were 80 cases out of 100, it was decided to ask for a Quality investigation (including cold chain) of all three batches (correct numbers: AFLUA350BA, AFLUA320BA and AFLUA320AA). On 16 January 2009, QA results were received for batches reviewed of (AFLUA320AA and AFLUA 320BA): AFLUCA320, AFLUA320A, and AFLUA320B. The report indicated that no deviation that could be linked to the complaint and no cold chain deviation was recorded on the batches AFLUA320AA and AFLUA320BA. On 26 March 2009, QA results were received for batches reviewed (AFLUA350BA): AFLUCA350 and AFLUA350B. The report indicated that no deviation that could be linked to the complaint and no cold chain deviation was recorded on the batch AFLUA350BA.
tired, loss of appetite Narrative: following Covid-19 vaccine (unsure of exact dates but occurred between 2/24 and 3/4), patient reported episodes of hypoglycemia . Patient stated he was shaking and "just felt terrible" . Wife states patient had two episodes of BG 45 and 66 last week after his COVID vaccine. He did say he was feeling very tired and didn't want to eat (he thought from the vaccine). Once he ate it did go up to 88 then 108 an hour after.
Pain at injection site that spread to shoulder joint, under arm and down toward elbow, around to back, and up toward neck.  Difficulty sleeping.  Soreness was severe upon movement of arm in the night (worse between 1:30a.m. and 1:00p.m.).  General feeling of sickness and fatigue for approximately 30 hours after vaccination. Arm itching and sore to the touch and difficulty raising it 39 hours after vaccination.  Received first Pneumovax in 2000.
hospitalized 1/19 due to right chest pain - diagnosed with bilateral pulmonary emboli
extreme fatigue, weakness, numbness in left arm, left side of face, and in both legs, tachycardia, palpitations, chest tightness, brain fog, internal vibrations, tinnitus, blurred vision, sleeping issues  Physical Therapy- No  Improvement Vitamin B12 shots- Minor improvement to weakness
headache and dizziness started 3 days after vaccination. found to have hematoma in brain on 10/26/23.
Severe nasal drip leading me to believe that I might have Strep Throat since I had been careful to wear a mask and didn?t knowingly come in contact with anyone having Covid-19
Pt. refers began feeling funny at 1 pm. By 2 pm she started itching all over arms, trunk & neck. She presented hives & rash on the above areas including groin. Didn't c/o SOB or throat closing. She was given BENADRYL 25 mg IM & Rx for ZYRTEC10 mg & BENADRYL 25 mg PO.
Given bivalent covid booster  on 2/13/2023 then discovered on the vaccination record show bivalent covid booster given through health department on 09/09/2022; attempted to contact patient with no answer. Message left on voicemail to call clinic back. Unknown if any adverse outcomes have occured.
Black looking rash and swelling on left arm. The rash disappears after a short while then appears again. It comes on without warning and disappears before one has time to go to see a doctor or emergency room. It itches and increases in size if she scratches. This has continued through out the years since then.
COVID arm after the 2nd dose; Red rash on her right arm where she got the vaccine after the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm after the 2nd dose) and VACCINATION SITE RASH (Red rash on her right arm where she got the vaccine after the 2nd dose) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN, PRAVASTATIN, MELOXICAM, HYDROXYZINE and GABAPENTIN for an unknown indication.   On 03-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm after the 2nd dose) and VACCINATION SITE RASH (Red rash on her right arm where she got the vaccine after the 2nd dose). At the time of the report, VACCINATION SITE REACTION (COVID arm after the 2nd dose) and VACCINATION SITE RASH (Red rash on her right arm where she got the vaccine after the 2nd dose) outcome was unknown.            The patient did not experience side effects after the 1st dose. Patient didn't take any treatment medications but applied an ice pack to the area.    Reporter did not allow further contact
Hardness, heat, redness and swelling at the injection sight.  By 10:00 PM sight swelling doubled in size.
He tested positive for COVID-19 on 6/15/22. He had a cough, congestion, runny nose, body aches, fever, and fatigue. He was not prescribed medication. I was giving him over-the-counter medication, TYLENOL and ZARBEE'S. He is doing better, but he still has a cough that will not go away. It gets worse when he gets excited.